Business Wire

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
BetaKit

Variational AI lands “up to” $349 million USD to discover drugs with Merck

Vancouver firm's AI platform will generate chemical compounds based on Merck’s therapeutic targets. A Vancouver startup using artificial intelligence (AI) to discover new drugs has struck a deal with ...
The Globe and Mail

Variational AI inks drug discovery deal with Merck worth up to $349-million

Variational AI Inc., a Vancouver startup that uses generative artificial intelligence to discover therapeutic drugs, has signed a two-year development deal with Merck & Co. Inc. MRK-N that could be ...

Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery and Variational ...